Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2016)

Historic Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Q4 2016 value amounting to $64000.0.

  • Viridian Therapeutics, Inc.\DE's Inventory fell 6577.54% to $64000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $64000.0, marking a year-over-year decrease of 6577.54%. This contributed to the annual value of $64000.0 for FY2016, which is 6577.54% down from last year.
  • According to the latest figures from Q4 2016, Viridian Therapeutics, Inc.\DE's Inventory is $64000.0, which was down 6577.54% from $62000.0 recorded in Q3 2016.
  • Viridian Therapeutics, Inc.\DE's Inventory's 5-year high stood at $536000.0 during Q2 2015, with a 5-year trough of $62000.0 in Q3 2016.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Inventory averaged around $239018.5, with its median value being $213000.0 (2016).
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 17751.89% in 2015, then plummeted by 8296.7% in 2016.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's Inventory (Quarter) stood at $179000.0 in 2014, then increased by 4.47% to $187000.0 in 2015, then crashed by 65.78% to $64000.0 in 2016.
  • Its last three reported values are $64000.0 in Q4 2016, $62000.0 for Q3 2016, and $213000.0 during Q2 2016.